These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11716486)

  • 1. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
    Noto H; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
    Biochem Biophys Res Commun; 2001 Nov; 289(2):395-401. PubMed ID: 11716486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
    Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
    Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.
    Sorenson RC; Bisgaier CL; Aviram M; Hsu C; Billecke S; La Du BN
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2214-25. PubMed ID: 10479665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
    Gaidukov L; Tawfik DS
    Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity.
    Thomàs-Moyà E; Gianotti M; Lladó I; Proenza AM
    J Nutr Biochem; 2006 Mar; 17(3):197-203. PubMed ID: 16214326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
    James RW; Deakin SP
    Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum reserve cholesterol binding capacity (SRCBC): the relative importance of different lipoprotein classes.
    Børresen AL; Berg K
    Artery; 1981; 9(2):96-119. PubMed ID: 6794547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of paraoxonase (PON1) status requires more than genotyping.
    Richter RJ; Furlong CE
    Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
    Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
    Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
    Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
    Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma congolense: paraoxonase 1 prolongs survival of infected mice.
    Bhasin KK; Yu JM; Tward A; Shih D; Campbell DA; Lusis AJ
    Exp Parasitol; 2006 Nov; 114(3):240-5. PubMed ID: 16682028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
    Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
    Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.